MicroRNA 670 (miR-670)

MicroRNA 670 (miR-670) is a small, endogenous, non-coding RNA molecule of approximately 22 nucleotides that functions primarily in the post-transcriptional regulation of gene expression[1][2][5]. Like other miRNAs, it is transcribed as part of a longer primary transcript by RNA polymerase II, processed by Drosha into a precursor, and further by Dicer into the mature miRNA, which is loaded into the RISC complex. Within RISC, miR-670 recognizes specific mRNAs by sequence complementarity, resulting in repression of translation or mRNA degradation. MiR-670 targets genes such as Igf2bp1, impacting cellular processes like methylation (m6A modification), cell cycle progression, and apoptosis[2]. Clinically, alterations in MIR670 expression have been associated with certain cancers and could play a role in developmental defects and possibly autoimmune pathology[1][2][7]. No direct drug interactions or biomarker status is established, and its therapeutic modulation may present developmental or off-target safety challenges.

Other names

hsa-miR-670MIR670microRNA 670miR-670-3pMIR670 RNAhsa-mir-670

Regulates gene expression by base-pairing with target mRNAs, resulting in translational inhibition or mRNA destabilization via the RNA-induced silencing complex (RISC)[1][2].